You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Virus-Like Particle Based pan-Marburgvirus Vaccine
SBC: LUNA INNOVATIONS INCORPORATED Topic: CBD18A002Marburg virus (MARV) is a filamentous enveloped non-segmented negative sense RNA virus. This viruse is considered to be extremelydangerous with case fatality rates as high as 88-90%. Extensive efforts have gone towards effective vaccines for MARV prevention, however,none have been successfully established as licensed vaccines. Glycoprotein (GP) is the only surface protein of MARV. There are substa ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Smart Morphing Moulage Medical (SM3) Training Platform
SBC: LUNA INNOVATIONS INCORPORATED Topic: DHA17A002Medical moulage is used in medical training to simulate injuries or pathologies, however current moulage is static and does not provide the trainee feedback on the quality of care or ultimate outcome of that care. Allowing a trainee to witness the injury or pathology -morph- while treatment is being provided can provide feedback on any potential mistreatment and enhance the learning and proficienc ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Probabilistic Pharmacokinetic Models for Diagnosis, Prognosis, and Personalized Treatment
SBC: BARRON ASSOCIATES, INC. Topic: DHA17B003Clinicians have recognized that the nature of diseases can be highly individual resulting in different patterns of onset and progression. In turn, the response of an individual to drugs is also unique and governed by a variety of factors. Pharmacokinetic models represent the movement of a drug through the body, and personalized pharmacokinetic models aim to capture the unique responses of specific ...
STTR Phase I 2018 Department of DefenseDefense Health Agency -
POC Blood Coagulopathy Monitor
SBC: CFD RESEARCH CORPORATION Topic: DHA19A001Traumatic injuries account for 30% of all life years lost in the US and is the leading cause of death for people under 46 years of age. Uncontrolled bleeding or hemorrhage constitute 30-40% of trauma related deaths and are considered to be a major cause o
STTR Phase I 2019 Department of DefenseDefense Health Agency -
Passive Pneumatic Prosthetic Ankle with Biomimetic Response
SBC: ADA TECHNOLOGIES, INC. Topic: DHP16C007The Defense Health Program seeks to improve the lives of service members suffering below knee amputations through the development of a non-powered lower extremity prosthesis designed to restore range of motion and power generation to that of an uninjured anatomical ankle. Current passive systems are still in early stages of development and typically only address one aspect of what the Defense Heal ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...
STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Functionalized, Therapeutic-Loaded Liposomes for the Acute Treatment of TBI
SBC: LUNA INNOVATIONS INCORPORATED Topic: DHA18A001Traumatic brain injury is a common problem in both the military and civilian communities, but current treatment protocols are focused on managing symptoms and fail to prevent significant long-term repercussions. In the proposed program, Luna will demonstrate the feasibility of a liposome-based therapeutic delivery system capable of delivering hydrophilic and hydrophobic therapeutics to the traumat ...
STTR Phase I 2018 Department of DefenseDefense Health Agency -
Electrotextile Systems for Human Signatures Monitoring
SBC: MANTEL TECHNOLOGIES, INC. Topic: DHA17A001Investments by the Department of Defense (DOD) have led to the development and demonstration of electronic textiles capable of transforming traditional textile systems into wearable power and data systems. The Defense Health Agency (DHA) has identified an opportunity to leverage advancements in smart garment systems for military personnel to aid in the prediction in performance declines and healt ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Developing Software for Pharmacodynamics and Bioassay Studies
SBC: TConneX Inc. Topic: DHP16C001Thegoal is to develop asoftwaretool that implementsa novelapproach applicableto fitgeneral pharmacologic, toxicology, or other biomedical data, that mayexhibita non-monotonic dose-responserelationship for which thecurrent parametricmodels fail. Thesoftwareexplores dose-responserelationships using both monotonicand non-monotonicmodels,and estimates theassociated doseresponsecurves,which can further ...
STTR Phase II 2019 Department of DefenseDefense Health Agency